ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
ABILIFY Now Applicable to Maintenance Treatment of Bipolar Disorder: FDA Approves New Indication
Tokyo (JCNN) - Bristrol-Myers Squibb (BMS) and Otsuka Pharmaceutical have jointly announced that the US Food and Drug
Administration (FDA) approved an additional indication for ABILIFY (aripiprazole) Tablets and Oral Solution, atypical
antipsychotics, as of March 1.
With this approval, ABILIFY is now applicable to the maintenance treatment, namely preventing relapses, of bipolar I
disorder. Since its initial approval in 2002, over 3.7 million prescriptions have been written in the US.
In Japan, ABILIFY , for which a new drug application was filed in March 2003, is currently under examination.
View Otsuka Pharmaceutical Co., Ltd. company
profile here
Copyright © 2001-2004 JCNN. All rights reserved. A
division of Japan Corporate News Network KK.
View drug information on Abilify.
ABILIFY Acum se aplicã de întreþinere Tratamentul de tulburarea bipolarã: FDA aprobã New Indicarea - ABILIFY Now Applicable to Maintenance Treatment of Bipolar Disorder: FDA Approves New Indication - articole medicale engleza - startsanatate